期刊文献+

Effects of Triggering Oocytes Maturation by rhCG 250 μg vs uhCG 10 000 IU on the Outcomes of IVF-ET Treatment in Chinese Population:A Cohort Study 被引量:1

Effects of Triggering Oocytes Maturation by rhCG 250 μg vs uhCG 10 000 IU on the Outcomes of IVF-ET Treatment in Chinese Population:A Cohort Study
原文传递
导出
摘要 Objective To compare the effects of recombinant hCG (rhCG) 250 μg and urinary hCG (uhCG) 10 000 1U on triggering oocyte maturation during COH/1VF-ET in Chinese women. Methods A retrospective cohort study which included COH/1VF-ET cases at reproductive medical center of Peking University Third Hospital from March to May 2010 was performed. Analysis of covariance (ANCOVA) was taken for data analysis. Results There were 318 cycles (group A) using rhCG 250μg and 810 cycles (group B) using uhCG 10 000 1U for triggering. In 1VF procedure, there were no significant differences in the number of oocyte retrieval, 2PN fertilization rate, good-quality embryo rate, embryo implantation rate and clinical pregnancy rate between the two groups. The delivery weeks, mean neonatal birth weight and live birth rates were also similar between the two groups. There was no local allergic reaction after injection or neonatal birth defect in group A. Conclusion The rhCG 250 μg and uhCG 10 000 IU have equal effects on triggering oocyte maturation for patients with normal ovarian function in Chinese population. rhCG may have even lower local discomfort occurrence. Objective To compare the effects of recombinant hCG (rhCG) 250 μg and urinary hCG (uhCG) 10 000 1U on triggering oocyte maturation during COH/1VF-ET in Chinese women. Methods A retrospective cohort study which included COH/1VF-ET cases at reproductive medical center of Peking University Third Hospital from March to May 2010 was performed. Analysis of covariance (ANCOVA) was taken for data analysis. Results There were 318 cycles (group A) using rhCG 250μg and 810 cycles (group B) using uhCG 10 000 1U for triggering. In 1VF procedure, there were no significant differences in the number of oocyte retrieval, 2PN fertilization rate, good-quality embryo rate, embryo implantation rate and clinical pregnancy rate between the two groups. The delivery weeks, mean neonatal birth weight and live birth rates were also similar between the two groups. There was no local allergic reaction after injection or neonatal birth defect in group A. Conclusion The rhCG 250 μg and uhCG 10 000 IU have equal effects on triggering oocyte maturation for patients with normal ovarian function in Chinese population. rhCG may have even lower local discomfort occurrence.
出处 《Journal of Reproduction and Contraception》 CAS 2013年第1期21-29,共9页 生殖与避孕(英文版)
关键词 recombinant hCG (rhCG) urinary hCG (uhCG) in vitro fertilization-embryo transfer (IVF-ET) recombinant hCG (rhCG) urinary hCG (uhCG) in vitro fertilization-embryo transfer (IVF-ET)
  • 相关文献

参考文献1

二级参考文献13

  • 1Driscoll GL, Tyler JP, Hangan JT, et al. A prospective, random- ized, controlled, double - blind, double - dummy comparison of re- combinant and urinary HCG for inducing oocyte maturation and follic- ular luteinization in ovarian stimulation [ J ]. Hum Reprod, 2000, 15 : 1305 - 1310.
  • 2Peter K, Timea K, Artur B, et al. Comparison of serum and follicu- lar fluid hormone levels with recombinant and urinary human ehorion- ic gonadotropin during in vitro fertilization [J]. Fertil Steril, 2008, 90:2133-2137.
  • 3A1 - Inany H, Aboulghar AM, Mansour RT, et al. Recombinant ver- sus urinary gonadotrophins for triggering ovulation in assisted concep- tion[J]. Hum Reprod, 2005, 20:2061 -2073.
  • 4The European Recombinant Human Chroionic Gonadotrophin Study Group. Induction of final follicular maturation and early luteini - zation in women undergoing ovulation induction for assisted reproduc- tion treatment- recombinant HCG versus urinary FICG[ J]. Hum Re- prod, 2000, 15:1446-1451.
  • 5Farrag A, Costantini C, Manna G, et al. Recombinant HCG for trig- gering ovulation increases the rate of mature oocytes in women treated for ICSI[J]. J Assist Reprod Genet, 2008, 25 : 461 -466.
  • 6Ludwig M, Doody KJ, Doody KM. Use of recombinant human choti- onic gonadotropin in ovulation induction [ J 1. Fertil Steril, 2003,79: 1051 - 1059.
  • 7Whitman- Elia GF, Banks K, O'Dea LS. Recombinant follicle- stimulating hormone in a patient hypersensitive to urinary - derived gonadotrophins[ J]. Gynecol Endocrinol, 1998, 12 : 209 - 212.
  • 8Penarrubia J, Balasch J, Fabregues F, et al. Recurrent empty follicle syndrome successfully treated with recombinant human chorionic gon- adotrophin[ J]. Hum Reprod, 1999,14 : 1703 - 1706.
  • 9Esposito MA, Patrizio P. Partial follicular aspiration for salvaging an IVF cycle after improper hCG administration: A case report[J]. J Reprod Med, 2000,45 : 511 -514.
  • 10Ndukwe G, Thornton S, Fishel S, et al. "Curing" empty follicle syndrome[J]. Hum Repmd, 1997,12:21 -23.

共引文献1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部